ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619677; 2) Community: the network communities that were significantly associated with the response to NSC 619677; 3) Molecule: the relationships between components within communities and NSC 619677; 4) MDR: the compounds that were significantly associated with the NSC 619677.

NSC Compound Enrichment Correlation
NSC 6926 Null 0.0434721470609156 0.29922024
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0434721470609156 0.56990668
NSC 715407 Null 0.0434721470609156 0.35887731
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.17621492
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0434721470609156 0.37697904
NSC 722996 2-(4-chloro-benzyl)-1H-naphth[2,3-d]imidazole 0.0434721470609156 -0.084960324
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.3441065
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0434721470609156 0.2361396
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0434721470609156 0.36901511
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0434721470609156 0.43145978
Total:129  Current:102    [First] [Prev] [Next] [Last]